drugset
drugset / Trial / NCT00380705

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

NCT00380705 ↗

Phase 4 Completed 91 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Allow physicians not familiar with anti-leukotriene based therapy to test it

Timeline

Start
2005-03-18
Primary completion
2005-07-29
Completion
2005-07-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified — —

Indications

allergic rhinitis asthma